Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quantum Genomics (QNNTF)
OTHER OTC:QNNTF
Holding QNNTF?
Track your performance easily
QNNTF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.09 - $3.58
Previous Close$0.1
Volume4.00K
Average Volume (3M)N/A
Market Cap
$6.41M
Enterprise Value-$11.37M
Total Cash (Recent Filing)€19.58M
Total Debt (Recent Filing)€3.40M
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Mar 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.38
R-Squared0.00133
Alpha-0.24
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)877.75
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
QNNTF FAQ
What was Quantum Genomics’s price range in the past 12 months?
Quantum Genomics lowest stock price was $0.09 and its highest was $3.58 in the past 12 months.
What is Quantum Genomics’s market cap?
Currently, no data Available
When is Quantum Genomics’s upcoming earnings report date?
Quantum Genomics’s upcoming earnings report date is Mar 28, 2024 which is 205 days ago.
How were Quantum Genomics’s earnings last quarter?
Currently, no data Available
Is Quantum Genomics overvalued?
According to Wall Street analysts Quantum Genomics’s price is currently Overvalued.
Does Quantum Genomics pay dividends?
Quantum Genomics does not currently pay dividends.
What is Quantum Genomics’s EPS estimate?
Quantum Genomics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quantum Genomics have?
Quantum Genomics has 69,709,950 shares outstanding.
What happened to Quantum Genomics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Quantum Genomics?
Currently, no hedge funds are holding shares in QNNTF
---
Quantum Genomics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Quantum Genomics
Quantum Genomics SA is a biopharmaceutical company, which develops new medication class for cardiovascular disease, such as high blood pressure and heart failure. It engages in research programs, that are based on the brain inhibition mechanism of aminopeptidase. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.
---
Technical Analysis
Bioxcel Therapeutics
―
CASI Pharmaceuticals
―
Cellectar Biosciences
―
Galera Therapeutics
―
---